v3.26.1
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Unaudited) - CAD ($)
Issued capital [member]
Reserve of share-based payments [member]
Warrant reserve [member]
Retained earnings [member]
Reserve of gains and losses from investments in equity instruments [member]
Reserve of exchange differences on translation [member]
Total
Balance at Dec. 31, 2024 $ 110,742,984 $ 7,698,304 $ 3,776,428 $ (117,465,829) $ (609,420) $ 479,316 $ 4,621,783
Balance, shares at Dec. 31, 2024 5,427,795            
IfrsStatementLineItems [Line Items]              
Shares issued for financing $ 22,628,469 22,628,469
Shares issued for financing, shares 7,215,000            
Share issue costs - Financing $ (3,059,837) 796,555 (2,263,282)
Warrants issued 1,103,825 1,103,825
Shares issued for exercise of overallotment $ 265,971 265,971
Shares issued for exercise of overallotment, shares 100,000            
Shares issue costs – overallotment $ (28,030) (28,030)
Shares issued for exercise of warrants $ 4,304,475 (128,668) 4,175,807
Shares issued for the exercise of warrants, shares 1,184,167            
Shares issued for exercise of RSU’s $ 935,730 (935,730)
Shares issued for the exercise of RSUs, shares 41,016            
Share-based payments 664,334 664,334
Net loss (8,186,986) (8,186,986)
Change in fair value of equity investments at FVOCI 14,285 14,285
Translation of foreign operations (10,645) (10,645)
Balance at Jun. 30, 2025 $ 135,789,762 8,223,463 4,751,585 (125,652,815) (595,135) 468,671 22,985,531
Balance, shares at Jun. 30, 2025 13,967,978            
IfrsStatementLineItems [Line Items]              
Shares issued for financing $ 34,279,276 34,279,276
Shares issued for financing, shares 4,672,895            
Share issue costs - Financing $ (4,241,065) 1,429,172 (2,811,893)
Shares issued for exercise of warrants $ 63,557,141 (2,716,408) (4,625,051) 56,215,682
Shares issued for the exercise of warrants, shares 10,528,180            
Shares issued for exercise of RSU’s $ 313,393 (313,393)
Shares issued for the exercise of RSUs, shares 175,722            
Share-based payments 724,623 724,623
Net loss (14,794,093) (14,794,093)
Unrealized gain on investments available for sale 50,001 50,001
Other comprehensive income (loss) (52,332) (52,332)
Balance at Dec. 31, 2025 $ 229,698,507 7,347,457 126,534 (140,446,908) (545,134) 416,339 96,596,795
Balance, shares at Dec. 31, 2025 29,344,775            
IfrsStatementLineItems [Line Items]              
Shares issued for financing $ 48,033,503 48,033,503
Shares issued for financing, shares 5,030,000            
Share issue costs - Financing $ (5,729,246) 2,976,520 (2,752,726)
Shares issued for exercise of warrants $ 19,367,257 19,367,257
Shares issued for the exercise of warrants, shares 2,121,164            
Shares issued for exercise of RSU’s $ 4,535,969 (4,535,969)
Shares issued for the exercise of RSUs, shares 652,584            
Share-based payments 5,168,279 5,168,279
Net loss (17,661,700) (17,661,700)
Unrealized gain on investments available for sale (42,857) (42,857)
Other comprehensive income (loss) 161,609 161,609
Balance at Jun. 30, 2026 $ 295,905,990 $ 10,956,287 $ 126,534 $ (158,108,608) $ (587,991) $ 577,948 $ 148,870,160
Balance, shares at Jun. 30, 2026 37,148,523